Ask the experts

We're here to help you with your drug development challenges.

Talk to our scientific panel

Whether your question is associated with optimizing your formulation or manufacturing process, or planning your clinical pharmacology study, we are here to help. Learn more about our experience and ask our team a question today.
  • Stuart Mair - Medical Director at Quotient Sciences

    Dr. Stuart Mair

    Global Vice President, Medical, Early Development

  • Andrew Lewis

    Vice President, Pharmaceutical Sciences

  • Nazim Kanji

    Executive Director, Pediatric Services

  • Asma Patel - Vice President, Integrated Development Services at Quotient Sciences

    Dr. Asma Patel

    Vice President, Integrated Development Services

  • Dr Vanessa Zann - Senior Research Fellow, Biopharmaceutics & Clinical Pharmacology

    Dr. Vanessa Zann

    Senior Drug Development Consultant

  • Iain Shaw - Director of 14 C Enabled Drug Development

    Iain Shaw

    Director, 14-C Enabled Drug Development

  • Alison Wilby

    Director of Modelling & Simulation

  • Stuart McDougall

    Vice President of BioAnalysis

  • Paul Quigley

    Head of Production, Drug Substance

  • Gareth Jenkins - Science and Technology Director at Quotient Sciences

    Gareth Jenkins

    VP Science and Technology, Candidate Development Services

  • Jeff Baisley

    VP, Commercial Operations, Commercial

  • Helen Baker

    Director, Pharmaceutical Sciences

Thank you for getting in touch with us.

We will send you a reply in the next 48 hours.
If you have not heard from us in the next 48 hours, do not hesitate to call us on:
UK +44 (0)115 974 9000 / US +1-800-769-3518

And finally your details

Get in touch
Humanity can’t afford to wait, so neither can we.
Let’s talk.